Phase Ib trial of gilteritinib in combination with mitoxantrone, cladribine, cytarabine and filgrastim (GM-CLAG) for relapsed/refractory FLT3-mutated acute myeloid leukemia

  • Hildebrandt, Gerhard (PI)

Grants and Contracts Details

StatusActive
Effective start/end date1/17/2212/5/22